Zhongzhu Healthcare Holding Co.,Ltd (SHA:600568)
China · Delayed Price · Currency is CNY 2.280
+0.050 (2.24%)
Jul 30, 2026, 9:25 AM CST
SHA:600568 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 544.73 | 577.34 | 521.39 | 638.56 | 505.97 | 581.06 |
Revenue Growth | 2.23% | 10.73% | -18.35% | 26.21% | -12.92% | -20.13% |
Gross Profit Gross Profit Growth | 79.5 | 93.5 | -51.32 | -56.42 | 109.89 | 124.63 |
Operating Income Operating Income Growth | -74.15 | -71.48 | -272.86 | -331.66 | -212.37 | -109.57 |
Net Income Net Income Growth | -116.46 | -114.19 | -620.22 | -343.94 | -799.26 | -211.28 |
Earnings Per Share EPS Growth | -0.06 | -0.06 | -0.31 | -0.17 | -0.40 | -0.11 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Medical Division Medical Division Growth | 396.1 |
Property development division Property development division Growth | 125.57 |
Financial Leasing Division Financial Leasing Division Growth | 5.38 |
Offset of Business Segment Offset of Business Segment Growth | -12.21 |
Pharmaceutical and others Pharmaceutical and others Growth | 62.51 |
Total Total Growth | 577.34 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 377.41 | 411.3 | 425.97 | 608.06 | 612.18 | 643.59 |
Total Debt Total Debt Growth | 21.82 | 22.12 | 15.63 | 18.46 | 273.02 | 283.9 |
Net Cash (Debt) Net Cash Growth | 355.59 | 389.18 | 410.33 | 589.6 | 339.17 | 359.69 |
Net Cash Growth | -13.25% | -5.16% | -30.40% | 73.84% | -5.70% | -45.71% |
Net Cash Per Share Net Cash Per Share Growth | 0.19 | 0.20 | 0.21 | 0.30 | 0.17 | 0.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 21.68 | 56.08 | 32.63 | 2.77 | 25.52 | 94.04 |
Capital Expenditures CapEx Growth | -33.62 | -32.08 | -12.82 | -27.26 | -25.95 | -63 |
Free Cash Flow Free Cash Flow Growth | -11.94 | 24 | 19.81 | -24.49 | -0.43 | 31.04 |
Free Cash Flow Growth | - | 21.18% | - | - | - | -79.09% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 14.59% | 16.20% | -9.84% | -8.84% | 21.72% | 21.45% |
Operating Margin | -13.61% | -12.38% | -52.33% | -51.94% | -41.97% | -18.86% |
Pretax Margin | -23.21% | -21.04% | -120.31% | -52.99% | -158.38% | -32.26% |
Profit Margin | -21.38% | -19.78% | -118.96% | -53.86% | -157.97% | -36.36% |
FCF Margin | -2.19% | 4.16% | 3.80% | -3.84% | -0.08% | 5.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 44.14 | 44.14 | 44.14 | 44.14 | 44.14 |
P/FCF Ratio | - | 201.96 | 130.80 | - | - | 125.83 |
PS Ratio | 8.08 | 8.40 | 4.97 | 5.37 | 7.41 | 6.72 |